Related Experiment Videos
Interstitial radiation therapeutic techniques at Mount Vernon Hospital
Acta Radiologica. Oncology
|January 1, 1982
Summary
Radium needle implants for tongue cancer show good survival rates but highlight challenges in local recurrence, especially for T2 tumors. Afterloading techniques and iridium-192 show promise for improved treatment outcomes and safety.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Carcinoma of the tongue, particularly on the lateral border, presents treatment challenges.
- Radium needle implantation has been a historical treatment modality for these cancers.
- Understanding recurrence patterns is crucial for improving patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of radium needle implant monotherapy for tongue cancer.
- To analyze local recurrence rates and identify contributing factors.
- To explore potential improvements in brachytherapy techniques.
Main Methods:
- Retrospective analysis of 56 tongue cancer cases treated with radium needle implant.
- Calculation of 5-year actuarial survival and local recurrence rates stratified by T-stage (T1N0, T2N0).
- Comparison with historical data for breast cancer treated with radium implant.
Main Results:
- 5-year actuarial survival: 75.3% for T1N0 and 81.8% for T2N0 tongue cancer.
- 5-year local recurrence: 17.5% for T1N0 and 35% for T2N0 tongue cancer.
- High local recurrence (66.2%) noted in breast cancer cases treated with radium implant.
Conclusions:
- Radium needle implant monotherapy offers moderate survival for early-stage tongue cancer.
- Local recurrences in tongue cancer are linked to inadequate tumor coverage by the implant.
- Afterloading techniques and 192Ir warrant further investigation for improved brachytherapy efficacy and safety.